JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | (FY)Dec 31, 2020 | (Q9)Sep 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | |||||||||
Earning before tax | -17.97%-55.95M | 10.62%-105.75M | -5.75%-47.43M | 6.47%-118.32M | ---44.85M | 20.61%-126.5M | -50.80%-92.96M | ---159.33M | ---61.64M |
Profit adjustment | |||||||||
Investment loss (gain) | ---- | ---- | ---- | 82.88%-463K | ---445K | -115.97%-2.7M | -112.98%-2.17M | ---1.25M | ---1.02M |
Impairment and provisions: | ---- | 508.89%548K | 49.21%-32K | -38.78%90K | ---63K | 212.77%147K | 293.85%126K | --47K | ---65K |
-Impairmen of inventory (reversal) | ---- | 342.61%279K | ---- | -496.55%-115K | ---- | -32.56%29K | 169.74%53K | --43K | ---76K |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2K |
-Other impairments and provisions | ---- | 31.22%269K | 49.21%-32K | 73.73%205K | ---63K | 2,850.00%118K | 461.54%73K | --4K | --13K |
Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | 94.68%-24K | ---305K | ---451K |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | 94.68%-24K | ---305K | ---451K |
Asset sale loss (gain): | -181.82%-9K | ---- | --11K | -99.12%1K | ---- | --114K | --57K | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | -99.19%1K | ---- | --123K | --66K | ---- | ---- |
-Loss (gain) from selling other assets | -181.82%-9K | ---- | --11K | ---- | ---- | ---9K | ---9K | ---- | ---- |
Depreciation and amortization: | 39.81%6.13M | 23.50%9.43M | 16.20%4.38M | 70.78%7.63M | --3.77M | 42.04%4.47M | 19.08%2.77M | --3.15M | --2.32M |
-Amortization of intangible assets | 11.11%10K | -5.26%18K | 0.00%9K | 280.00%19K | --9K | --5K | --2K | ---- | ---- |
Financial expense | 30.54%436K | 10.90%651K | 23.70%334K | 56.53%587K | --270K | 772.09%375K | 529.73%233K | --43K | --37K |
Exchange Loss (gain) | 73.80%-833K | 35.16%-1.7M | -121.38%-3.18M | -562.43%-2.62M | ---1.44M | 18,800.00%567K | ---166K | --3K | ---- |
Special items | -14.04%8.54M | -2.36%19.87M | -2.24%9.94M | -70.42%20.35M | --10.17M | -38.72%68.8M | 110.55%66.58M | --112.27M | --31.62M |
Operating profit before the change of operating capital | -15.89%-41.69M | 17.03%-76.95M | -10.39%-35.97M | -69.44%-92.74M | ---32.59M | -20.60%-54.73M | 12.47%-25.56M | ---45.39M | ---29.2M |
Change of operating capital | |||||||||
Inventory (increase) decrease | 149.09%2.56M | 42.04%-4.71M | 9.04%-5.21M | -124.16%-8.12M | ---5.72M | -150.07%-3.62M | -20.48%-2.15M | ---1.45M | ---1.78M |
Accounts receivable (increase)decrease | ---- | ---- | ---19K | ---- | ---- | ---- | ---- | --2.16M | --2.16M |
Accounts payable increase (decrease) | 39.03%-6.32M | -154.53%-5.37M | -194.43%-10.36M | 115.25%9.85M | --10.97M | -48.65%4.58M | -155.10%-2.07M | --8.91M | --3.75M |
prepayments (increase)decrease | 45.60%-3.9M | 21.36%-6.54M | 42.74%-7.17M | -129.44%-8.32M | ---12.53M | -473.99%-3.62M | 10.65%-2.65M | --969K | ---2.97M |
Special items for working capital changes | -184.64%-744K | ---- | --879K | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from business operations | 13.41%-50.1M | 5.80%-93.56M | -45.12%-57.85M | -73.03%-99.32M | ---39.86M | -64.99%-57.4M | -15.66%-32.42M | ---34.79M | ---28.03M |
Special items of business | 24.17%-298K | -197.69%-2.33M | -627.78%-393K | 146.85%2.38M | ---54K | -959.63%-5.09M | -574.89%-3.06M | --592K | ---454K |
Net cash from operations | 13.48%-50.39M | 1.08%-95.89M | -45.91%-58.24M | -55.12%-96.94M | ---39.92M | -82.73%-62.49M | -24.57%-35.49M | ---34.2M | ---28.49M |
Cash flow from investment activities | |||||||||
Sale of fixed assets | --6K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of fixed assets | 21.36%-1.43M | -115.45%-15.1M | 18.96%-1.81M | 43.63%-7.01M | ---2.24M | -720.86%-12.44M | -1,067.75%-11.88M | ---1.52M | ---1.02M |
Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---64K | ---- | ---- | ---- |
Recovery of cash from investments | ---- | ---- | ---- | -67.36%243.56M | --210.3M | 430.88%746.13M | 550.81%747.39M | --140.54M | --114.84M |
Cash on investment | ---- | ---- | ---- | 66.14%-243.1M | ---209.85M | -540.87%-717.9M | -643.42%-728.7M | ---112.02M | ---98.02M |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---72K | ---- | ---- | ---- |
Net cash from investment operations | 21.69%-1.42M | -130.69%-15.1M | -1.17%-1.81M | -141.83%-6.55M | ---1.79M | -42.05%15.65M | -56.89%6.81M | --27.01M | --15.8M |
Net cash before financing | 13.73%-51.81M | -7.26%-111M | -43.99%-60.06M | -120.94%-103.48M | ---41.71M | -551.43%-46.84M | -126.05%-28.67M | ---7.19M | ---12.69M |
Cash flow from financing activities | |||||||||
New borrowing | --20M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Issuing shares | ---- | ---- | ---- | -8.25%187.52M | ---- | --204.38M | --209.86M | ---- | ---- |
Interest paid - financing | ---57K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | 45.96%-8.24M | -63.84%-8.24M | -248.97%-15.24M | ---5.03M | ---4.37M | ---8.28M | ---- | ---- |
Net cash from financing operations | 266.86%17.16M | -108.08%-13.68M | -66.06%-10.29M | -14.34%169.4M | ---6.19M | 32,624.18%197.75M | 36,945.30%200.07M | ---608K | ---543K |
Effect of rate | -72.38%810K | -37.14%1.66M | 92.33%2.93M | 599.81%2.64M | --1.53M | -444.33%-528K | 556.82%201K | ---97K | ---44K |
Net Cash | 50.74%-34.65M | -289.15%-124.68M | -46.84%-70.34M | -56.32%65.92M | ---47.9M | 2,035.23%150.91M | 1,395.71%171.4M | ---7.8M | ---13.23M |
Begining period cash | -54.33%103.4M | 43.43%226.42M | 43.43%226.42M | 2,008.83%157.87M | --157.87M | -51.33%7.49M | -51.33%7.49M | --15.38M | --15.38M |
Cash at the end | -56.25%69.56M | -54.33%103.4M | 42.63%159.01M | 43.43%226.42M | --111.49M | 2,008.83%157.87M | 8,391.37%179.08M | --7.49M | --2.11M |
Cash balance analysis | |||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.